In This Article:
-
Revenue: $7.42 million, representing an 18.7% increase over Q2 2024 and 111% year-over-year growth.
-
Gross Margin: B2B2C business gross margins rose to 83%; overall business gross margins reached 70% on a non-GAAP basis.
-
Operating Expenses: Non-GAAP operating expenses reduced to $12.3 million, a 15.9% sequential decline from Q2 2024.
-
Client Wins: 10 new client wins in Q3, with an expectation of 17 to 20 new clients for the second half of the year.
-
Projected Client Growth: Estimated total of 25 new client signings in 2024, representing approximately 35% growth in the client base.
-
Cash Flow Projection: On track to reach cash flow break-even run rate by the end of 2025.
Release Date: November 07, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
DarioHealth Corp (NASDAQ:DRIO) reported a significant revenue increase of 111% year-over-year, reaching $7.42 million in Q3 2024.
-
The company achieved a gross margin of 83% in its B2B2C business, reflecting strong operational efficiency.
-
DarioHealth Corp (NASDAQ:DRIO) secured 10 new client contracts in Q3 2024, with expectations to add 5 more by year-end, indicating strong business momentum.
-
The company successfully reduced non-GAAP operating expenses by 15.9% sequentially, demonstrating effective cost management.
-
DarioHealth Corp (NASDAQ:DRIO) transitioned its Pharma business to a subscription-based model, enhancing revenue predictability and stability.
Negative Points
-
Despite revenue growth, DarioHealth Corp (NASDAQ:DRIO) is not yet cash flow positive, with a target to achieve this by the end of 2025.
-
The company faces challenges in converting new client logos into meaningful revenues efficiently.
-
DarioHealth Corp (NASDAQ:DRIO) is still in the process of integrating recent acquisitions, which may pose operational challenges.
-
The transition from milestone-based to subscription-based revenue in the Pharma channel may initially create revenue volatility.
-
The company is undergoing significant organizational changes, including budget reallocations, which could impact short-term operational stability.
Q & A Highlights
Q: As we approach 2025, can you provide some guidance on how we should think about the 2025 growth range for B2B2C revenue? A: Erez Raphael, CEO: We have around 25 new clients this year, which is more than a 30% increase in our client base. While we are not providing precise guidance, we expect to reach a $50 million run rate by the end of next year, which will make the company operationally cash flow positive.